27th National Clinical Education Symposium Presentation Abstracts

Actions for Presentation

Download PDF Back to list

Other presentations

The Effect of Online Mindfulness-Based Stress Reduction on Mindfulness, Pain Severity, Functionality, and Somatosensory Temporal Discrimination Ability in Patients with Fibromyalgia Syndrome - Page S79
Sena Çağlayan, Selcuk Aslan, Merve Çöldür, Selim Yasin Boğa, Zafer Günendi

Determination of iron deficiency rates in male patients with depressive disorder: preliminary results - Page S80
Merve Şahin Can, Rıza Gökçer Tulacı, Çiğdem Kaçkan

Relationship Between Systemic Inflammatory Markers and Lithium Response in Bipolar 1 Disorder - Page S81
Olcay Şenay, Bahri İnce

The Relationship Between Attention Deficit Hyperactivity Disorder Symptoms, Time Perspective Perception, and Suicide in University Students - Page S82
Güssüm Bakırcı, Rukiye Ay Diker

Evaluation of Cases Referred to a Forensic Psychiatry Outpatient Clinic in Terms of Demographic and Clinical Characteristics: A Two-Year Retrospective Study - Page S83
Beliz Naz Akyıldız, Nursema Öztürk, İlkay Keleş Altun

Sociodemographic and Clinical Characteristics of Older Patients Admitted to an Inpatient Psychiatry Clinic - Page S84
Alp Yakut, HACER ARIKAN, Vildan Cakir Kardes

29 APRIL 2025, TUESDAY
11:45-13:00 ORAL PRESENTATION SESSION - 6

Investigation of Depression, Social Anxiety Disorder, Functionality, and Quality of Life Levels in Patients with Pterygium: A Case-Control Study

Şeyma Sehlikoğlu1, Burak Ören1

1. Department of Psychiatry, Adıyaman University, Faculty of Medicine, Adıyaman, Turkey

DOI: 10.5080/kes27.abs54 Page 78

BACKGROUND AND AIM:Pterygium, a degenerative fibrovascular disease, can cause redness, reduced visual acuity, psychological distress, and aesthetic concerns. This study aims to assess the severity of social anxiety, depression, functionality, and health-related quality of life in patients with pterygium, and to compare their mental health with a control group.
METHODS (Ethics Committee Approval must be obtained and the number should be specified.):This case-control study was conducted between March 20, 2024, and August 20, 2024, involving 35 patients with pterygium and a control group of 35 age-, gender-, and chronic disease-matched individuals. All participants completed a sociodemographic data form, the Liebowitz Social Anxiety Scale (LSAS), the Sheehan Disability Scale (SDS), the Beck Depression Inventory (BDI), and the Short Form-36 questionnaire. The study was approved by the Adıyaman University Non-Interventional Clinical Research Ethics Committee (Decision number: 2024/3-9, dated 19/03/2024).
RESULTS:The patient group was found to have significantly lower scores in energy, vitality, and mental health compared to the control group (t = 2.71, p = 0.008; t = 1.79, p = 0.05, respectively). Additionally, the patient group experienced significantly higher levels of social anxiety than the control group (t = 1.97, p <0.05). A positive correlation was observed in the patient group between the SDS social life scores and both the total LSAS scores (r = 0.428, p = 0.01) and BDI scores (r = 0.616, p <0.001).
CONCLUSIONS:This study highlights that patients with pterygium exhibit significantly higher levels of social anxiety compared to the control group, along with notably lower quality of life scores in terms of energy, vitality, and mental health. Furthermore, the findings suggest that the degree of disability may increase the risk of social anxiety and depression. These results underscore the importance of incorporating psychological evaluation and support into the clinical management of pterygium patients to improve their overall well-being.